MedTrace Logo

Establishing Clinical Significance in Rotator Cuff Disease

NCT06677320 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 69

Last updated 2025-03-04

No results posted yet for this study

Summary

The goal of this observational study is to learn about rotator cuff patients. The main questions it aims to answer are:

* What is the minimal clinically important difference value of the Shoulder Disability Questionnaire, the short version of the Western Ontario Rotator Cuff Index, the Shoulder Rating Questionnaire, and the University of California-Los Angeles Shoulder Scale?
* What is the substantial clinical benefit value of the Shoulder Disability Questionnaire, the short version of the Western Ontario Rotator Cuff Index, the Shoulder Rating Questionnaire, and the University of California-Los Angeles Shoulder Scale?
* What is the patient-acceptable symptomatic state value of the Shoulder Disability Questionnaire, the short version of the Western Ontario Rotator Cuff Index, the Shoulder Rating Questionnaire, and the University of California-Los Angeles Shoulder Scale?
* What is the maximal outcome improvement value of the Shoulder Disability Questionnaire, the short version of the Western Ontario Rotator Cuff Index, the Shoulder Rating Questionnaire, and the University of California-Los Angeles Shoulder Scale?
* What are the risk factors that prevent rotator cuff patients from reaching the minimal clinically important difference value?
* What are the risk factors that prevent rotator cuff patients from reaching the substantial clinical benefit value?
* What are the risk factors that prevent rotator cuff patients from reaching the patient-acceptable symptomatic state value?
* What are the risk factors that prevent rotator cuff patients from reaching the maximal outcome improvement value?

Conditions

  • Rotator Cuff Disease

Interventions

OTHER

Exercise

Patients with rotator cuff disease will receive exercise treatment for two months.

Sponsors & Collaborators

  • Kırklareli University

    lead OTHER

Principal Investigators

  • Ozan Gür, MSc · Kırklareli University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-03-03
Primary Completion
2026-06-30
Completion
2026-06-30

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06677320 on ClinicalTrials.gov